4
Changes in Ownership
Cue Biopharma, Inc. Filed Acc 0001209191-23-021201
Director sold 9,325 shares at $3.28 ($30,586)
- Director acquired 9,682 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kiener Peter A Director | 2023-03-23 | Option exercise | +9,682 | $2.86 | $27,691 | 9,682 | D: show line 1 in the form |
| Kiener Peter A Director | 2023-03-23 | Sale | −9,325 | $3.28 | $30,586 | 357 | D: show line 2 in the form |
| Open-market sales · 9,325 sh · avg $3.28 · $30,586 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Kiener Peter A Director | 2023-03-23 | Option exercise · Stock Option (right to buy) | −9,682 | 96,062 | D: show line 3 in the form |
Loading xslF345X04/doc4.xml…